Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nodular Sclerosis Classical Hodgkin Lymphoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT00302003
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Who this might be right for
Childhood Favorable Prognosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin Lymphoma+3 more
Children's Oncology Group 287
Testing effectiveness (Phase 2)Study completedNCT00082966
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Mixed Cellularity Hodgkin LymphomaAdult Nodular Sclerosis Hodgkin Lymphoma+1 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00070304
What this trial is testing

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT01460940
What this trial is testing

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT01476410
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+4 more
Northwestern University 48
Large-scale testing (Phase 3)Study completedNCT00049595
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 552
Large-scale testing (Phase 3)Active Not RecruitingNCT03907488
What this trial is testing

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Lymphocyte-Depleted Classic Hodgkin LymphomaAnn Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma+7 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00398554
What this trial is testing

Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Christine Mauz-Körholz 16
Large-scale testing (Phase 3)Study completedNCT00002561
What this trial is testing

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

Who this might be right for
Hodgkin Lymphoma
NCIC Clinical Trials Group 405
Large-scale testing (Phase 3)Study completedNCT00433459
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Christine Mauz-Körholz 2,134
Testing effectiveness (Phase 2)Study completedNCT00574496
What this trial is testing

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00822120
What this trial is testing

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Who this might be right for
LymphomaNonneoplastic Condition
SWOG Cancer Research Network 371
Large-scale testing (Phase 3)Study completedNCT00678327
What this trial is testing

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Who this might be right for
Lymphoma
University College, London 1,202
Testing effectiveness (Phase 2)Study completedNCT01118026
What this trial is testing

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 101
Not applicableStudy completedNCT01366157
What this trial is testing

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 23
Testing effectiveness (Phase 2)Study completedNCT00369681
What this trial is testing

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Study completedNCT00002715
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Stanford University 50
Testing effectiveness (Phase 2)Study completedNCT00666484
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Who this might be right for
LymphomaNeurotoxicity
University College, London 47
Not applicableStudy completedNCT00305149
What this trial is testing

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNodular SclerosisMixed Cellularity+2 more
Rambam Health Care Campus 130
Load More Results
994